Amogen Pharma Private Limited, a active private limited company, was established on 15 July 2020 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33110TG2020PTC141754. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹20.00 Cr.
It upholds a compliant status. Employing 27 professional, Its leadership includes Poosapati Venkata Surya Narasimha Raju (Director), Devi Kalyan Kumar Thakasi (Director), Akhilesh Raju Poosapati (Director). Past directors included Devi Kalyan Kumar Thakasi. It holds ₹75.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 7 & 8, Survey No 3 To 6 Madhapur,Durgam Cheruvu Road, Hyderabad, Telangana, 500084.
U33110TG2020PTC141754
141754
15 July 2020
₹20.00 Cr
₹20.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Amogen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Poosapati Venkata Surya Narasimha Raju | Director | 15 Jul 2020 | Current |
| Devi Kalyan Kumar Thakasi | Director | 21 Nov 2022 | Current |
| Akhilesh Raju Poosapati | Director | 15 Jul 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amogen Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 149173.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Amogen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹750,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2023 | Others | ₹75.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amogen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amogen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amogen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Amogen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Amogen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge with Others amounted to Rs. 75.00 Cr with Charge ID 100772865 was registered on 15 Jul 2023. was documented.
The activity Devi Kalyan Kumar Thakasi was appointed as a Director was appointed as a Director on 21 Nov 2022 & has been associated with this company since 3 years 1 month . was completed.
Poosapati Venkata Surya Narasimha Raju was appointed as a Director was appointed as a Director on 15 Jul 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
Progress on Akhilesh Raju Poosapati was appointed as a Director was appointed as a Director on 15 Jul 2020 & has been associated with this company since 5 years 6 months . was documented.
The CIN of Amogen Pharma Private Limited is U33110TG2020PTC141754.
Amogen Pharma Private Limited is headquartered at Plot No 7 & 8, Survey No 3 To 6 Madhapur,Durgam Cheruvu Road, Hyderabad, Telangana, 500084.
Amogen Pharma Private Limited was incorporated on 15 July 2020.
The current directors of Amogen Pharma Private Limited are
The primary industry of Amogen Pharma Private Limited is Pharma.
Amogen Pharma Private Limited is unlisted.
The authorized capital of Amogen Pharma Private Limited is ₹20.00 Cr, and the paid-up capital is ₹20.00 Cr.
The compliance status of Amogen Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX